Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan
Clinical trial NCT00276445 · TERMINATED
Trial details
- NCT number
- NCT00276445
- Sponsor
- Meiji University of Oriental Medicine
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.